Rapport Therapeutics, Inc. (RAPP) vs Tyra Biosciences, Inc. (TYRA)

Rapport Therapeutics, Inc. and Tyra Biosciences, Inc. are both Biotechnology companies. Rapport Therapeutics, Inc. and Tyra Biosciences, Inc. are of similar size ($1.6B and $1.5B). Across the 8 metrics below, Rapport Therapeutics, Inc. leads on 7 and Tyra Biosciences, Inc. on 1.

Valuation

Metric RAPP TYRA Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 3.81 4.07 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (8.96%) (11.01%) (28.84%)
Free cash flow yield (6.02%) (7.64%) (23.03%)

Profitability

Metric RAPP TYRA Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (39.96%) (45.31%) (57.72%)
Return on assets (36.85%) (42.15%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric RAPP TYRA Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 24.34% (33.11%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric RAPP TYRA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 15.72 14.91 4.73
Net debt to EBITDA 3.91 1.94 0.96

Dividend

Metric RAPP TYRA Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric RAPP TYRA Biotechnology median
Market cap 1.58b 1.54b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack